Truvy

Vy Boost

Serving

1 Capsule(s)

Per container

Form

capsule-unknown

DSLD

264464

Formula hash

cfc775ba1929

Brand context

Truvy

Catalog

products

With avoid flag

products

FDA recalls

history

CAERS

reports

Avoid-flaggedObjective label signals

Flagged excipients

1 avoid · 1 caution

FDA recalls

no recall history

CAERS reports

FDA consumer events

Certifications

none recorded

1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

3 active ingredients

Ingredient	Amount	% DV
Vitamin B6 vitaminUNII · KV2JZ1BI6Z UL · set6 effects	2.5 mg	147%
Iron mineralUNII · E1UOL152H7 UL · set5 effects	1.5 mg	8%
Proprietary Blend Proprietary Blend (Combination)other	457 mg	—

What this product supports · authorized claims

8 authority-backed effects

Rolled up from EFSA / FDA / NIH ODS authorized function claims on this product's active ingredients. Each row shows which ingredients contribute.

↑Normal energy-yielding metabolism
from: Vitamin B6
EFSAEU-Reg-432/2012-ID-75 →
↑Normal nervous system function
from: Vitamin B6
EFSAEU-Reg-432/2012-ID-66 →
↑Normal immune system function
from: Iron · Vitamin B6
EFSAEU-Reg-432/2012-ID-73 →
↑Normal formation of red blood cells + hemoglobin
from: Iron · Vitamin B6
EFSAEU-Reg-432/2012-ID-67 →LOINC 789-8
↑Normal cognitive function
from: Iron
EFSAEU-Reg-432/2012-ID-253 →
↑Normal oxygen transport in the body
from: Iron
EFSAEU-Reg-432/2012-ID-252 →LOINC 718-7
↓Normal homocysteine metabolism
from: Vitamin B6
EFSAEU-Reg-432/2012-ID-77 →LOINC 13965-9
↓Reduction of tiredness and fatigue
from: Iron · Vitamin B6
EFSAEU-Reg-432/2012-ID-78 →

Flagged excipients

2 flagged · authority citations

● AVOIDTitanium Dioxide
color
Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.
eur-lex.europa.eu →efsa.europa.eu →ecfr.gov →
◐ CAUTIONFD&C Yellow #5
color
EU requires warning label 'may have an adverse effect on activity and attention in children' per Commission Regulation 1333/2008 Annex III (following Southampton study 2007). FDA requires specific label declaration (21 CFR 74.705).
eur-lex.europa.eu →ecfr.gov →

FDA CAERS · adverse event context

consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Hypromellose · Carmine · Microcrystalline Cellulose · Magnesium Stearate · Silicon Dioxide

Chemically equivalent

Same formula, different brand

Products with identical sorted (ingredient, amount) tuples.

TruVision
truControl
→